Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
83% of peptide-aware Americans want the FDA to make peptides more accessible Days before an FDA advisory committee meets to consider whether seven widely used peptides BPC-157, TB-500, KPV, MOTS-c, Emideltide (DSIP), Semax, and Epitalon should become eligible for compounding, a new survey suggests thats what Americans want
By promoting actin polymerization and cell migration, TB-500 moves repair cells from the surrounding tissue into the damaged tendon
At that concentration, a 250 mcg dose equals exactly 0.1mL, or 10 units on a U-100 syringe
Its selectivity makes it ideal for long-term use with minimal side effects
Food and Drug Administration (1)
US$ 23.62
US$ 27.64
US$ 28.86
US$ 21.88
US$ 23.46
US$ 29.02
US$ 26.89
US$ 25.01
US$ 22.80
US$ 27.69
